PriceTargets.com logo

Labcorp - LH Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $297.07
  • Forecasted Upside: 13.64%
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$261.42 As of 12/4/2025 04:59 PM ET
▼ -4.34 (-1.63%)

This chart shows the closing price for LH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Labcorp Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LH

Analyst Price Target is $297.07
▲ +13.64% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Labcorp in the last 3 months. The average price target is $297.07, with a high forecast of $320.00 and a low forecast of $260.00. The average price target represents a 13.64% upside from the last price of $261.42.

This chart shows the closing price for LH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 16 contributing investment analysts is to moderate buy stock in Labcorp. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/7/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$291.00 ➝ $317.00
10/29/2025UBS GroupLower TargetBuy ➝ Buy$325.00 ➝ $320.00
10/29/2025Robert W. BairdSet Target$304.00
10/17/2025MizuhoBoost TargetOutperform ➝ Outperform$285.00 ➝ $320.00
10/17/2025UBS GroupBoost TargetBuy ➝ Buy$305.00 ➝ $325.00
10/14/2025Truist FinancialSet Target$320.00
10/8/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
10/3/2025Evercore ISIBoost TargetOutperform ➝ Outperform$300.00 ➝ $305.00
10/2/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$275.00 ➝ $290.00
9/27/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
8/25/2025Robert W. BairdSet Target$311.00
7/25/2025UBS GroupBoost TargetBuy ➝ Buy$282.00 ➝ $305.00
7/25/2025Truist FinancialBoost TargetBuy ➝ Buy$290.00 ➝ $310.00
7/25/2025Evercore ISIBoost TargetOutperform ➝ Outperform$285.00 ➝ $300.00
7/25/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$283.00 ➝ $306.00
7/25/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$290.00 ➝ $302.00
7/18/2025UBS GroupLower TargetBuy ➝ Buy$284.00 ➝ $282.00
7/10/2025Hsbc Global ResDowngradeStrong-Buy ➝ Hold
7/10/2025HSBCDowngradeBuy ➝ Hold$260.00
7/9/2025Evercore ISIBoost TargetOutperform ➝ Outperform$260.00 ➝ $285.00
6/25/2025BarclaysReiterated RatingCautious ➝ Cautious
6/25/2025BarclaysSet TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.00
6/11/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$270.00 ➝ $283.00
5/12/2025Truist FinancialBoost TargetBuy ➝ Buy$274.00 ➝ $290.00
5/6/2025Piper SandlerReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00
4/30/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.00
4/30/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$253.00 ➝ $267.00
4/11/2025Truist FinancialLower TargetBuy ➝ Buy$285.00 ➝ $274.00
4/10/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$260.00 ➝ $240.00
4/2/2025Redburn AtlanticInitiated CoverageBuy$276.00
3/4/2025CitigroupUpgradeNeutral ➝ Buy$250.00 ➝ $300.00
2/10/2025Piper SandlerBoost TargetNeutral ➝ Neutral$240.00 ➝ $260.00
2/7/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$271.00 ➝ $260.00
2/6/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$275.00 ➝ $290.00
2/3/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$249.00 ➝ $271.00
1/28/2025UBS GroupLower TargetBuy ➝ Buy$293.00 ➝ $286.00
1/7/2025Evercore ISIUpgradeIn-Line ➝ Outperform$260.00 ➝ $265.00
12/17/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$260.00 ➝ $270.00
12/13/2024Bank of AmericaBoost TargetBuy ➝ Buy$262.00 ➝ $271.00
12/10/2024Jefferies Financial GroupReiterated RatingBuy$265.00 ➝ $275.00
10/30/2024Hsbc Global ResUpgradeHold ➝ Strong-Buy
10/30/2024HSBCUpgradeHold ➝ Buy
10/28/2024Piper SandlerBoost TargetNeutral ➝ Neutral$235.00 ➝ $240.00
10/25/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$234.00 ➝ $249.00
10/25/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$282.00 ➝ $289.00
10/16/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$249.00 ➝ $234.00
10/1/2024Piper SandlerInitiated CoverageNeutral$235.00
9/24/2024Evercore ISILower TargetIn-Line ➝ In-Line$250.00 ➝ $240.00
9/23/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$245.00 ➝ $265.00
9/20/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$278.00 ➝ $282.00
8/5/2024Bank of AmericaBoost TargetBuy ➝ Buy$240.00 ➝ $260.00
8/2/2024UBS GroupBoost TargetBuy ➝ Buy$260.00 ➝ $270.00
8/2/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$220.00 ➝ $230.00
8/2/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$213.00 ➝ $249.00
8/2/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$261.00 ➝ $277.00
8/2/2024Truist FinancialBoost TargetBuy ➝ Buy$255.00 ➝ $275.00
7/9/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$210.00 ➝ $215.00
7/8/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$258.00 ➝ $261.00
5/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$261.00 ➝ $243.00
4/26/2024Truist FinancialLower TargetBuy ➝ Buy$270.00 ➝ $255.00
4/26/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$234.00 ➝ $213.00
4/26/2024Robert W. BairdLower TargetOutperform ➝ Outperform$255.00 ➝ $244.00
3/25/2024ArgusUpgradeHold ➝ Buy$250.00
2/26/2024Leerink PartnrsReiterated RatingOutperform
2/26/2024Leerink PartnersInitiated CoverageOutperform$260.00
2/9/2024Evercore ISIInitiated CoverageIn-Line$240.00
1/3/2024BarclaysInitiated CoverageEqual Weight$222.00
11/17/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$259.00 ➝ $261.00
10/31/2023MizuhoLower TargetBuy ➝ Buy$257.00 ➝ $230.00
9/21/2023Bank of AmericaLower TargetBuy ➝ Buy$238.00 ➝ $230.00
9/18/2023UBS GroupLower Target$255.00 ➝ $250.00
9/18/2023Robert W. BairdLower TargetOutperform ➝ Outperform$251.00 ➝ $237.00
9/15/2023MizuhoReiterated RatingBuy ➝ Buy$257.00
9/15/2023Truist FinancialReiterated RatingBuy ➝ Buy$270.00
9/6/2023HSBCInitiated CoverageHold$210.00
8/14/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$290.00 ➝ $270.00
8/3/2023Morgan StanleyLower TargetOverweight ➝ Overweight$285.00 ➝ $260.00
8/2/2023Credit Suisse GroupLower TargetOutperform ➝ Outperform$247.41 ➝ $231.00
7/31/2023Robert W. BairdLower TargetOutperform ➝ Outperform$255.00 ➝ $251.00
7/28/2023Truist FinancialLower TargetBuy$275.00 ➝ $270.00
5/16/2023MizuhoLower Target$277.00 ➝ $257.00
5/1/2023Truist FinancialLower Target$285.00 ➝ $275.00
4/26/2023Deutsche Bank AktiengesellschaftLower Target$265.00 ➝ $240.00
4/26/2023CitigroupLower Target$260.00 ➝ $235.00
3/13/2023Credit Suisse GroupLower TargetOutperform$304.00 ➝ $288.00
2/21/2023Credit Suisse GroupLower TargetOutperform$305.00 ➝ $304.00
2/21/2023Wells Fargo & CompanyLower TargetOverweight$315.00 ➝ $290.00
2/17/2023Truist FinancialBoost TargetBuy$275.00 ➝ $285.00
2/17/2023CitigroupBoost TargetNeutral$250.00 ➝ $260.00
2/17/2023Robert W. BairdBoost TargetOutperform$300.00
2/17/2023MizuhoBoost TargetBuy$250.00 ➝ $277.00
1/11/2023Robert W. BairdBoost TargetOutperform$270.00 ➝ $285.00
1/6/2023Morgan StanleyBoost TargetOverweight$290.00 ➝ $303.00
12/12/2022CitigroupDowngradeBuy ➝ Neutral$275.00 ➝ $250.00
11/23/2022Credit Suisse GroupLower TargetOutperform$308.00 ➝ $305.00
11/3/2022MizuhoLower TargetBuy$296.00 ➝ $250.00
10/31/2022Morgan StanleyLower TargetOverweight$300.00 ➝ $290.00
10/28/2022Truist FinancialLower TargetBuy$275.00 ➝ $260.00
10/28/2022CitigroupLower Target$300.00 ➝ $275.00
10/28/2022Robert W. BairdLower Target$297.00 ➝ $270.00
10/27/2022William BlairReiterated RatingOutperform
9/19/2022ArgusDowngradeBuy ➝ Hold
8/22/2022Morgan StanleyReiterated RatingOverweight$300.00
8/9/2022Credit Suisse GroupLower Target$308.00
8/4/2022Robert W. BairdBoost TargetOutperform$295.00 ➝ $297.00
8/1/2022Credit Suisse GroupLower TargetOutperform$312.00 ➝ $308.00
5/25/2022Morgan StanleyLower TargetOverweight$360.00 ➝ $300.00
5/4/2022MizuhoLower Target$354.00 ➝ $323.00
5/3/2022Deutsche Bank AktiengesellschaftLower Target$294.00 ➝ $265.00
5/2/2022Credit Suisse GroupLower Target$344.00 ➝ $312.00
4/29/2022Truist FinancialLower Target$350.00 ➝ $320.00
4/25/2022Wells Fargo & CompanyLower TargetEqual Weight$290.00 ➝ $235.00
2/14/2022Morgan StanleyLower TargetOverweight$380.00 ➝ $360.00
2/11/2022Wells Fargo & CompanyLower Target$340.00 ➝ $320.00
2/11/2022Credit Suisse GroupBoost TargetOutperform$340.00 ➝ $344.00
2/11/2022CitigroupBoost Target$340.00 ➝ $350.00
1/28/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$330.00 ➝ $294.00
12/20/2021MizuhoBoost TargetBuy$332.00 ➝ $354.00
12/17/2021Morgan StanleyBoost TargetOverweight$377.00 ➝ $380.00
12/14/2021Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$330.00 ➝ $340.00
11/1/2021Credit Suisse GroupBoost TargetOutperform$336.00 ➝ $338.00
10/29/2021Morgan StanleyBoost TargetOverweight$368.00 ➝ $377.00
8/31/2021Morgan StanleyBoost TargetOverweight$273.00 ➝ $368.00
8/20/2021Credit Suisse GroupBoost TargetOutperform$295.00 ➝ $336.00
8/19/2021MizuhoBoost TargetBuy$318.00 ➝ $332.00
7/30/2021Truist FinancialBoost TargetPositive ➝ Buy$330.00 ➝ $350.00
7/30/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$297.00 ➝ $330.00
7/30/2021MizuhoBoost TargetBuy$310.00 ➝ $318.00
7/21/2021Robert W. BairdSet TargetBuy$276.78
5/20/2021ArgusBoost TargetAverage ➝ Buy$270.00 ➝ $295.00
5/12/2021MizuhoBoost TargetBuy$267.00 ➝ $310.00
5/3/2021Truist FinancialBoost Target$300.00 ➝ $320.00
5/3/2021CitigroupBoost Target$278.00 ➝ $312.00
5/3/2021Jefferies Financial GroupBoost TargetBuy$300.00 ➝ $310.00
4/14/2021Truist FinancialBoost TargetAbove Average ➝ Buy$280.00 ➝ $300.00
4/1/2021Jefferies Financial GroupReiterated RatingBuy
2/12/2021CitigroupBoost TargetBuy$257.00 ➝ $278.00
2/12/2021JPMorgan Chase & Co.Boost TargetOverweight$261.00 ➝ $279.00
2/12/2021MizuhoBoost TargetBuy$242.00 ➝ $267.00
1/29/2021CitigroupBoost TargetBuy$249.00 ➝ $257.00
1/14/2021MizuhoBoost TargetBuy$234.00 ➝ $242.00
1/11/2021ArgusUpgradeHold ➝ Buy$245.00
1/8/2021Wolfe ResearchDowngradeOutperform ➝ Peer Perform
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.40 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 26 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 68 very positive mentions
  • 37 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 77 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 46 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 53 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 69 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 69 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Labcorp logo
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Read More

Today's Range

Now: $261.42
Low: $259.42
High: $265.56

50 Day Range

MA: $269.95
Low: $245.96
High: $291.34

52 Week Range

Now: $261.42
Low: $209.38
High: $293.72

Volume

861,158 shs

Average Volume

928,922 shs

Market Capitalization

$21.67 billion

P/E Ratio

25.68

Dividend Yield

1.08%

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of Labcorp?

The following sell-side analysts have issued stock ratings on Labcorp in the last year: Bank of America Corporation, Barclays PLC, Citigroup Inc., Evercore ISI, Hsbc Global Res, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Redburn Atlantic, Robert W. Baird, Truist Financial Corporation, UBS Group AG, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for LH.

What is the current price target for Labcorp?

0 Wall Street analysts have set twelve-month price targets for Labcorp in the last year. Their average twelve-month price target is $297.07, suggesting a possible upside of 13.6%. UBS Group AG has the highest price target set, predicting LH will reach $320.00 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of $260.00 for Labcorp in the next year.
View the latest price targets for LH.

What is the current consensus analyst rating for Labcorp?

Labcorp currently has 4 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for LH.

What other companies compete with Labcorp?

Other companies that are similar to Labcorp include Hologic, Henry Schein, Medpace, AMN Healthcare Services and Cardinal Health. Learn More about companies similar to Labcorp.

How do I contact Labcorp's investor relations team?

Labcorp's physical mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company's listed phone number is (336) 229-1127 and its investor relations email address is [email protected]. The official website for Labcorp is www.labcorp.com. Learn More about contacing Labcorp investor relations.